When the promoter of PVT1 is non-functional, the intragenic enhancers rewire it towards the promoter of MYC with a topological rearrangement in the 3D genome that boosts the oncogenic expression of MYC, thus enhancing cancer cell proliferation [110]. The gene discussed is MYC; the disease is cancer.